johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

AOL · 12h

Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share.

Business Insider · 17h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

The Motley Fool on MSN · 17h

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript

Operator Good morning and welcome to Johnson & Johnson's fourth quarter 2024 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference.

Seeking Alpha · 13h

Johnson & Johnson Dips On Q4 Earnings: Here's What The Market Isn't Seeing

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ stock is a Buy.

Zacks.com on MSN · 17h

Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.

FDA approves Johnson & Johnson's nasal spray for depression

Fortune on MSN · 4h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

U.S. News & World Report · 12h

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,

Popular Science · 13h

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

14h

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

24m

Bears to interview Rams assistant head coach for defensive coordinator position

Chicago Bears head coach Ben Johnson has identified one of the NFL's top assistant coaches to interview for the team's defensive coordinator position.

WISN 12 NEWS24m

New Bears head coach takes a shot at Packers head coach Matt Lafleur

During his introductory press conference on Wednesday, Johnson took a shot at Packers head coach Matt LaFleur. He was ...

35m

Cracks emerge in House GOP after speaker’s threat to saddle California wildfire aid with conditions

Some U.S. House Republicans in California are breaking with Speaker Mike Johnson over his suggestion that federal disaster aid be coupled with as-yet unspecified conditions on the wildfire-ravaged ...

The Matt Eberflus errors Ben Johnson vows not to make as Bears coach

Sloppy ends to games plagued the previous Chicago coaching staff and their new coach says he considers these situations a ...

‘Gorgeous’ Jessica Simpson shows off her toned legs in low-cut swimsuit after Eric Johnson split

Jessica Simpson is showing off her revenge body! The “With You” songstress stunned in a plunging yellow one-piece swimsuit while promoting her new Jessica Simpson collection via Instagram. “New season ...

Amon-Ra St. Brown and Ben Johnson had a very NSFW goodbye after Bears hired Lions OC

Over the last three years, former Detroit Lions offensive coordinator Ben Johnson was instrumental in helping revitalize a ...

1hon MSN

Ben Johnson reveals key position group the Chicago Bears will prioritize improving this offseason

Chicago Bears head coach Ben Johnson is well aware of the position group his team must improve during the 2025 NFL offseason.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Johnson & Johnson Q4 Profit Decreases

FDA approves Johnson & Johnson's nasal spray for depression

Related topics